All News

As the “peptide craze” fuels a surge in unregulated vendors, pharmacists must serve as critical navigators to steer patients toward safe, pharmaceutical-grade alternatives.

GSK’s investigational drug for liver treatment was given fast-track designations to improve access in what the FDA considers a significant unmet medical need.

Following an FDA announcement on its deeper look into peptide restrictions, Christopher Shade, PhD, joined to provide insights on their functions for metabolic health and more.

Researchers find Reddit posts provides a look at the real-world adverse effects of glucagon-like peptide-1 receptor agonists.

Pharmacists have the expertise to address acute and chronic pain distinctions, missed-dose protocols, tolerance and safety insights, and multimodal, non-pharmacological strategies for pain.

The 2026 guidance emphasizes that selecting newer and innovative agents should occur early, dependent on comorbidities of the patient.

The FDA’s Pharmacy Compounding Advisory Committee will meet in late July of 2026 to convene on peptides and their inclusion on the 503A Bulk Drug Substances List.

A head-to-head trial shows a protein-based COVID-19 booster causes fewer adverse effects, boosting patient preference and aiding pharmacists.

Under a 12-month agreement, the Utah authorities granted companies permission to use generative AI to authorize medication refills for state residents.

FDA expands Tzield use to age 1 year to delay stage 3 type 1 diabetes, enabling earlier immune intervention.

New research examines what drives, or hinders, pharmacists when guiding patients through self-medication decisions for minor ailments like cold and flu.

In an exploration of pharmacists’ self-efficacy, researchers explored medication counseling outcomes for older adults across various languages.

Cloned pharmacy sites and fake GLP-1 weight-loss pens surge online, prompting federal crackdowns and urgent safety warnings for patients.

FDA approves Idvynso, a 2-drug HIV switch option for suppressed adults, supporting simpler care as people age with HIV and manage multiple conditions.

Researchers conduct an exploration of e-prescription challenges and potential across pharmacies in Germany.

The executive order mandates national priority vouchers for psychedelic drugs that have received breakthrough therapy designations.

Low pneumococcal vaccine rates have potential to significantly impact a variety of at-risk populations, even groups of certain health care workers.

New IL‑33 antibody cuts chronic obstructive pulmonary disease flare-ups in phase 3 trials, showing benefit and safety.

A long-term trial shows oral orforglipron boosts A1C and weight loss with reassuring cardiovascular safety and simpler dosing for type 2 diabetes.

Practical pharmacy wound care tips include choosing modern dressings, spotting infection red flags, and knowing when to refer.

Pharmacists optimize insulin therapy, including basal and bolus dosing, missed-dose tips, continuous glucose monitoring insights, and affordability.

New research shows older adults vaccinate more when confident navigating their health care.

Researchers measure exactly how much pharmacist-provided care is being underbilled and what gaps mean for the future of reimbursement.

New 2026 guidance backs long-term obesity drugs, spotlighting GLP-1 benefits, side effects, and off-label risks pharmacists must navigate.

Through the lens of changes in medication adherence, researchers assessed differences in CVD-related emergency department visits and total cost of care.

The drug could be an effective analgesia with a safety profile that could fundamentally alter the landscape of pain management and addiction treatment.

In a recent research letter, investigators establish how removal of in-person dispensing requirements impact mifepristone pharmacy access.

Exploring both patient-level and organizational factors, researchers assess community pharmacy accessibility for immunizations and injectables.